Blume Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Blume Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$138K	Hold	275	–	–	0.02%	144
2026 Q1	$135K	Hold	275	–	–	0.02%	134
2025 Q4	$159K	Sell	275 -50	-15%	-$28.3K	0.03%	124
2025 Q3	$158K	Hold	325	–	–	0.03%	125
2025 Q2	$132K	Hold	325	–	–	0.03%	135
2025 Q1	$162K	Hold	325	–	–	0.04%	122
2024 Q4	$169K	Hold	325	–	–	0.04%	120
2024 Q3	$201K	Hold	325	–	–	0.05%	113
2024 Q2	$180K	Sell	325 -50	-13%	-$28.6K	0.04%	110
2024 Q1	$218K	Sell	375 -25	-6%	-$14K	0.05%	94
2023 Q4	$212K	Hold	400	–	–	0.06%	88
2023 Q3	$202K	Hold	400	–	–	0.06%	91
2023 Q2	$209K	Hold	400	–	–	0.06%	89
2023 Q1	$231K	Sell	400 -30	-7%	-$16.9K	0.07%	81
2022 Q4	$237K	Hold	430	–	–	0.08%	86
2022 Q3	$218K	Hold	430	–	–	0.08%	75
2022 Q2	$234K	Hold	430	–	–	0.09%	74
2022 Q1	$254K	Hold	430	–	–	0.08%	71
2021 Q4	$287K	Hold	430	–	–	0.09%	75
2021 Q3	$246K	Hold	430	–	–	0.09%	76
2021 Q2	$217K	Hold	430	–	–	0.08%	79
2021 Q1	$196K	Buy	+430	New	+$205K	0.08%	78

Other funds holding TMO

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return

Blume Capital Management's TMO Position: Q2 2026 in Review

Blume Capital Management held its Thermo Fisher Scientific (TMO) position steady in Q2 2026 at 275 shares worth $138K. The position accounts for 0.02% of the portfolio, ranked #144.

Blume Capital Management first reported a position in TMO in Q1 2021 and has held it in 22 quarters since. The position peaked at $287K in Q4 2021. 1,172 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Blume Capital Management held 275 shares of Thermo Fisher Scientific worth $138K as of Q2 2026.
Blume Capital Management left its Thermo Fisher Scientific share count unchanged in Q2 2026.
Thermo Fisher Scientific made up 0.02% of Blume Capital Management's portfolio in Q2 2026, its #144 holding.
Blume Capital Management first reported a position in Thermo Fisher Scientific in Q1 2021 and has held it in 22 quarters since.
Blume Capital Management's Thermo Fisher Scientific position peaked at $287K in Q4 2021.
1,172 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Blume Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.